Deterioration of diabetic nephropathy via stimulating secretion of cytokines by atrial natriuretic peptide
Abstract Background Atrial natriuretic peptide (ANP) is a cardiovascular and metabolic hormone that has been identified recently as being associated with chronic kidney disease (CKD) without diabetes. Cytokines such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and adiponectin (ADP) contr...
Main Authors: | Chenxiao Liu, Qi Li, Xiu Feng, Jian Zhu, Qian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-021-00867-7 |
Similar Items
-
Mechanism of hypertension in diabetic nephropathy
by: Nazar Chaudhary Muhammad Junaid
Published: (2014-04-01) -
Serum atrial natriuretic peptide: a suspected biomarker of breast cancer
by: Maha E. Houssen, et al.
Published: (2017-03-01) -
Atrial natriuretic peptide and feeding activity patterns in rats
by: Oliveira M.H.A., et al.
Published: (1997-01-01) -
Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01) -
Complete loss of the atrial natriuretic peptide‐converting enzyme Corin and CHAF‐LA syndrome: Implications to natriuretic peptide physiology and left atrium health
by: Alina Kurolap, et al.
Published: (2024-01-01)